Investors who lost money on travere therapeutics, inc. should contact levi & korsinsky about an ongoing investigation - tvtx

New york, ny / accesswire / october 2, 2024 / levi & korsinsky notifies investors that it has commenced an investigation of travere therapeutics, inc. ("travere therapeutics, inc.") (nasdaq:tvtx) concerning possible violations of federal securities laws. travere issued a press release on september 26, 2024, "announc[ing] a voluntary pause of enrollment in the phase 3 harmony study evaluating pegtibatinase for the treatment of classical homocystinuria (hcu).
TVTX Ratings Summary
TVTX Quant Ranking